eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2020
vol. 16
 
Share:
Send email
Share:
abstract:
Short communication

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

Magdalena Dobrolińska
1
,
Paweł Gąsior
1
,
Tomasz Roleder
2
,
Magda Roleder-Dylewska
1
,
Grzegorz Smolka
1
,
Andrzej Ochała
1
,
Elvin Kedhi
1, 3
,
Wojciech Wojakowski
1

  1. Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
  2. Regional Specialist Hospital, Research and Development Center, Wroclaw, Poland
  3. AZ SintJan, Brugge, Belgium
Adv Interv Cardiol 2020; 16, 2 (60): 187–191
DOI: https://doi.org/10.5114/aic.2020.96062
Online publish date: 2020/06/23
View full text Get citation
 

Introduction

Technological improvements in drug-eluting stents (DES) have led to drastic reductions in restenosis and acute stent thrombosis rates. However, chronic inflammation and late and very late stent thrombosis, particularly with the first generation durable polymer DES (DP-DES), prompted the development of new DES platforms that use biodegradable polymers. The advantage of biodegradable polymers relies on the resorbable property of these polymers, reducing in this way the polymer-induced chronic inflammation and related clinical events such as restenosis and stent thrombosis. Notwithstanding , despite the theoretical advantages of bioabsorbable polymer DES (BP-DES), there are limited data focused on its very early vascular healing process.

Aim

Therefore, we aimed to assess the 1-month vascular healing response following implantation of the bioabsorbable polymer-coated sirolimus-eluting stent Alex Plus (BP-SES, Alex Plus, Balton, Warsaw, Poland).

Material and methods

Study population

In this prospective, single-centre study, patients aged 18 years and older undergoing percutaneous coronary intervention (PCI) for treatment of de novo coronary lesions with implantation of a bioresorbable polymer sirolimus-eluting stent (BP-SES), Alex Plus, for any clinical indication were enrolled. Major exclusive criteria were renal failure (glomerular filtration rate less than 45 ml/min/1.73 m2), allergy to contrast media or any of the stent components, hemodynamic compromise at presentation, pregnancy as well as participation in other clinical trials.

Stent system description

Alex Plus is composed of a laser-cut cobalt-chromium alloy stent platform with open-cell geometry and 71 µm struts with a fully biodegradable circumferential coating (copolymer of poly-L-lactic and glycolic acid) and the anti-proliferative drug sirolimus. Experimental studies showed 95% release of the drug after 28 days and practically full polymer biodegradation after 8 weeks following Alex Plus implantation [1].

Optical coherence tomography

Optimal coherence tomography (OCT) using iLumien OPTIS Medical system (Abbott Vascular, Santa Clara, CA, USA) imaging was performed before and after stent implantation as well as at 1-month follow-up. The OCT registration included the entire stented segment as well as 5 mm proximally and distally to the stent. The OCT image was acquired using automated pullback triggered...


View full text...
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.